CereVasc, Inc. is developing the eShunt^® System for the treatment of patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults.  Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions.  The eShunt System has the potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.